BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 5919966)

  • 1. [The therapeutic nightmare].
    Olin GA; Göth E; Liljestrand A; Werkö L
    Lakartidningen; 1966 Mar; 63(9):847-57. PubMed ID: 5919966
    [No Abstract]   [Full Text] [Related]  

  • 2. Fact sheet on Therapeutic Nightmare and "the pill".
    Hardt RA
    West Med Med J West; 1966 Feb; 7(2):21-5. PubMed ID: 5951980
    [No Abstract]   [Full Text] [Related]  

  • 3. Setting the record straight on PDR criticisms.
    Mehta M
    Postgrad Med; 2000 Jan; 107(1):22. PubMed ID: 10649658
    [No Abstract]   [Full Text] [Related]  

  • 4. Editorial: limitations of the physicians' desk reference 2007.
    Mindel JS; Teich SA; Teich CM; Beam P
    Surv Ophthalmol; 2008; 53(1):82-4. PubMed ID: 18191659
    [No Abstract]   [Full Text] [Related]  

  • 5. Retrospective view of the interfacial relationship of the pharmaceutical industry with the Food and Drug Administration and the United States Pharmacopeia.
    Hammer HF
    J Parenter Sci Technol; 1984; 38(4):159-63. PubMed ID: 6491859
    [No Abstract]   [Full Text] [Related]  

  • 6. Knowledge is power: legislative control of drug industry trade secrets.
    O'Reilly JT
    Spec Law Dig Health Care (Mon); 1987 May; 8(15):7-31. PubMed ID: 10281981
    [No Abstract]   [Full Text] [Related]  

  • 7. FDA action spurs change in groups' drug programs.
    Perry PA
    Hosp Mater Manage; 1989 Nov; 14(11):1, 13-4. PubMed ID: 10295911
    [No Abstract]   [Full Text] [Related]  

  • 8. Another round over generics.
    Kosterlitz J
    Natl J (Wash); 1985 Oct; 17(42):2373, 2376. PubMed ID: 10274030
    [No Abstract]   [Full Text] [Related]  

  • 9. Therapeutic orphans.
    Shirkey H
    Pediatrics; 1999 Sep; 104(3 Pt 2):583-4. PubMed ID: 10469793
    [No Abstract]   [Full Text] [Related]  

  • 10. The Prescription Drug User Fee Act: is a faster Food and Drug Administration always a better Food and Drug Administration?
    Zelenay JL
    Food Drug Law J; 2005; 60(2):261-338. PubMed ID: 16094773
    [No Abstract]   [Full Text] [Related]  

  • 11. Plugs for drugs.
    Masson A; Rubin PH
    Regulation; 1986; 10(1):37-43, 53. PubMed ID: 10280556
    [No Abstract]   [Full Text] [Related]  

  • 12. The United States Food and Drug Administration and the end of antibiotics.
    Shlaes DM; Moellering RC
    Clin Infect Dis; 2002 Feb; 34(3):420-2. PubMed ID: 11774094
    [No Abstract]   [Full Text] [Related]  

  • 13. What's in a name? Generic vs brand name drugs.
    Levin AA
    Health PAC Bull; 1986 Jun; 16(5):37, 39. PubMed ID: 10276741
    [No Abstract]   [Full Text] [Related]  

  • 14. An update on the therapeutic orphan.
    Wilson JT
    Pediatrics; 1999 Sep; 104(3 Pt 2):585-90. PubMed ID: 10469794
    [No Abstract]   [Full Text] [Related]  

  • 15. Bolar agrees to guilty plea in generic drug probe.
    Wagner M
    Mod Healthc; 1991 Mar; 21(9):17. PubMed ID: 10109180
    [No Abstract]   [Full Text] [Related]  

  • 16. Initial responses to recommendations of the Blue Ribbon Committee on Generic Medicines.
    Heller WM
    Am J Hosp Pharm; 1993 Feb; 50(2):318-22. PubMed ID: 8480792
    [No Abstract]   [Full Text] [Related]  

  • 17. Generic drug purchasing.
    Mehl B
    Hosp Pharm; 1988 Feb; 23(2):162-4 contd. PubMed ID: 10286432
    [No Abstract]   [Full Text] [Related]  

  • 18. Remarks by the Commissioner of Food and Drugs.
    Kessler DA
    Food Drug Law J; 1995; 50(2):327-34. PubMed ID: 10343001
    [No Abstract]   [Full Text] [Related]  

  • 19. The Food and Drug Administration drug registration and listing system.
    Slavin M
    Drug Inf J; 1975; 9(2-3):239-40. PubMed ID: 10236978
    [No Abstract]   [Full Text] [Related]  

  • 20. Personal responsibility and the Food and Drug Law.
    Janssen WF
    FDA Consum; 1975 Nov; 9(9):10-3. PubMed ID: 10308122
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.